Connect with us

Health

First FDA Approved Cannabis-Based Drug Available for Prescription

CBD has been known to treat seizures for years, but now the FDA is on board, making it legal for doctors to prescribe.

Published

on

Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration, is now available by prescription in all 50 states, according to its manufacturer GW Pharmaceuticals.

Epidiolex  is intended to treat seizures associated with two rare and severe forms of epilepsy that begin in childhood called Dravet syndrome, which is a rare genetic dysfunction of the brain that begins in the first year of life, and Lennox-Gastaut syndrome, a form of epilepsy with multiple types of seizures that begins in early childhood, usually between ages 3 and 5.

The drug is made of CBD, a component of marijuana that doesn’t give users a high and has been legal in the United States for years. According to CNN, Justin Gover, CEO of GW Pharmaceuticals, the maker of Epidiolex, said in a written statement.

“Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures, “We are committed to ensuring that these patients can access this novel cannabinoid medicine that has been thoroughly studied in clinical trials, manufactured to assure quality and consistency, and is eligible to be covered by insurance for appropriate patients.”

There is much hope and speculation that the FDA will be studying the effect of CBD, especially since the uprising in states that allow medical marijuana, with more than half of The United States legalizing it.

 

Are you looking for digital journalism training and experience? Are you a journalism major who wants to take your career to the next level? CMN’s Digital Journalism course gives you real-time experience, intense feedback on your writing, exposure to journalism influencers and mentors, and a great place to display your work. You can get academic credit too. Check out the Digital Journalism Course here.

Erin Whitten is currently CMN's Senior Correspondent and is currently a student at Arizona State University majoring in Mass Communications and Media Studies.

Sign up for the Morning Scoop

and wake up with us each day.

CMN Reports

Government15 hours ago

New York Governor Cuomo Pushes for Legalizing Recreational Marijuana in 2019

Today, New York Governor Andrew Cuomo announced that he will be pushing to legalize recreational marijuana in 2019, according to...

by , Mercy College
Government17 hours ago

Michael Flynn’s Business Associates Indicted

Michael Flynn, Trump’s first national security adviser, two former business associates were indicted as being a part of a federal...

by , Mercy College
National News4 days ago

Americans Still Favor Watching News to Reading News in a Latest Survey

While TV still dominants, digital media continues to grow rapidly and print and radio decline.

by , The Catholic American University
In the Hot Seat6 days ago

Michael Cohen Sentenced to 3 Years in Prison

President Trump’s former lawyer, Michael Cohen, was sentenced to three years in prison Wednesday for his role in the hush-money...

by , Mercy College
Entertainment6 days ago

Ambani-Piramal Wedding Celebrations include Beyonce and Hillary Clinton

India's richest man's daughter gets married.

by , Mercy College
National News6 days ago

Fatalities Reported at Strasbourg Christmas Market Shooting, Suspect Still at Large

France has currently upgraded their security threat level after terrorist attack leaves at least 12 injured

by , CMN Senior Correspondent
Academics2 weeks ago

Temple University Professor Marc Lamont Hill Faces More Trouble Over U.N. Speech

The Temple University professor is under fire from Temple for a U.N. speech critical of Israel.

by , The Catholic American University
National News4 weeks ago

Michigan State University Ex-President Charged in Larry Nassar Case

The investigation continues.

by , U. Alabama Birmingham

Top Reads